These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26976859)

  • 41. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a Pseudomonas aeruginosa co-producing NDM-1, VIM-5 and VIM-6 metallo-β-lactamases in Denmark using whole-genome sequencing.
    Wang M; Borris L; Aarestrup FM; Hasman H
    Int J Antimicrob Agents; 2015 Mar; 45(3):324-5. PubMed ID: 25542060
    [No Abstract]   [Full Text] [Related]  

  • 43. Emergence of a New Delhi metallo-β-lactamase-1-producing Pseudomonas aeruginosa in Singapore.
    Teo JW; La MV; Jureen R; Lin RT
    Emerg Microbes Infect; 2015 Nov; 4(11):e72. PubMed ID: 26632659
    [No Abstract]   [Full Text] [Related]  

  • 44. GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
    Kotsakis SD; Papagiannitsis CC; Tzelepi E; Legakis NJ; Miriagou V; Tzouvelekis LS
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1331-3. PubMed ID: 20065056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IMP-29, a novel IMP-type metallo-β-lactamase in Pseudomonas aeruginosa.
    Jeannot K; Poirel L; Robert-Nicoud M; Cholley P; Nordmann P; Plésiat P
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2187-90. PubMed ID: 22290960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland.
    Fiett J; Baraniak A; Mrówka A; Fleischer M; Drulis-Kawa Z; Naumiuk Ł; Samet A; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2006 Mar; 50(3):880-6. PubMed ID: 16495246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metallo-β-lactamase expression confers an advantage to Pseudomonas aeruginosa isolates compared with other β-lactam resistance mechanisms, favoring the prevalence of metallo-β-lactamase producers in a clinical environment.
    Corich L; Dolzani L; Tonin EA; Vitali LA; Lagatolla C
    Microb Drug Resist; 2010 Sep; 16(3):223-30. PubMed ID: 20735174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
    Ohlasova D; Kmet V; Niks M
    Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
    [No Abstract]   [Full Text] [Related]  

  • 49. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan.
    Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-beta-lactamase VIM-2 in a hematology unit of a French hospital.
    Aubron C; Poirel L; Fortineau N; Nicolas P; Collet L; Nordmann P
    Microb Drug Resist; 2005; 11(3):254-9. PubMed ID: 16201928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a novel metallo-β-lactamase VIM-28 located within unusual arrangement of class 1 integron structure in Pseudomonas aeruginosa isolates from Egypt.
    El-Mahdy TS
    Jpn J Infect Dis; 2014; 67(5):382-4. PubMed ID: 25241690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
    Wang C; Cai P; Chang D; Mi Z
    J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary.
    Libisch B; Watine J; Balogh B; Gacs M; Muzslay M; Szabó G; Füzi M
    Res Microbiol; 2008 Apr; 159(3):162-8. PubMed ID: 18280707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria.
    Touati M; Diene SM; Dekhil M; Djahoudi A; Racherache A; Rolain JM
    Antimicrob Agents Chemother; 2013 May; 57(5):2426-7. PubMed ID: 23459493
    [No Abstract]   [Full Text] [Related]  

  • 56. Emergence of metallo-β-lactamase IMP-14 and VIM-2 in Pseudomonas aeruginosa clinical isolates from a tertiary-level hospital in Thailand.
    Piyakul C; Tiyawisutsri R; Boonbumrung K
    Epidemiol Infect; 2012 Mar; 140(3):539-41. PubMed ID: 21733273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
    Hong JS; Yoon EJ; Lee H; Jeong SH; Lee K
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7216-7223. PubMed ID: 27671068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CTX-M and PER-1 group extended spectrum β-lactamases-producing Pseudomonas aeruginosa from the patients of lower respiratory tract infection.
    Saxena S; Banerjee G; Garg R; Singh M
    Indian J Med Microbiol; 2015; 33(1):191-2. PubMed ID: 25560041
    [No Abstract]   [Full Text] [Related]  

  • 59. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China.
    Chao Z; Xiao-Feng W; Dan-Hong S; Jin-Ping Y; Nan-Shan Z
    Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.
    Lagatolla C; Edalucci E; Dolzani L; Riccio ML; De Luca F; Medessi E; Rossolini GM; Tonin EA
    J Clin Microbiol; 2006 Jul; 44(7):2348-53. PubMed ID: 16825348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.